Malignancy involves cellular growth, movement, and metastasis. One of the key cellular check-points regulating these features is the binding of a secreted cytosolic molecule called amphoterin to the cell surface receptor for advanced glycation end products (RAGE). We found that this binding involves novel glycans that we discovered. This proposal explores the structure and function of the glycans that mediate these interactions. We have identified a new type of carboxylated N-linked oligosaccharide that is especially enriched in endothelial cells, embryonic neurons and cancer cells. Our biochemical and immunological evidence indicates that the antigen contains di-carboxylated amino acids amide-linked to the sugar chains. These novel glycans mediate endothelium/leukocyte binding, and intraperitoneal inflammation in vivo and neurite outgrowth in vitro. The carboxylated glycans directly bind to four proteins: amphoterin, annexin-I and S 100A8/A9, and S100A12, which have been linked in various ways to inflammation, septic shock, tumor growth or metastasis. We found that RAGE N-linked sugar chains contain the carboxylates and that they mediate amphoterin-RAGE binding and some of the multiple intracellular signaling events they ignite. To understand the role of the carboxylated glycans in this complex process, we propose to: 1. Establish the detailed structure of the carboxylated glycans on bovine RAGE and in neuroblastoma cells. 2. Determine the significance of carboxylated glycans in defining the pathophysiological functions of RAGE, in terms of ligand binding and intracellular signaling. 3. Assess the role of carboxylated glycans in mediating amphoterin-RAGE interactions in vitro and in vivo that lead to tumor growth, invasion, and metastasis.The fundamental understanding of the structure of these novel glycans together with their effects on tumor growth and metastasis are likely to add an important dimension to the understanding of these pathologies and may lead to novel therapeutic approaches to block them.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA092608-02
Application #
6605622
Study Section
Pathobiochemistry Study Section (PBC)
Program Officer
Jhappan, Chamelli
Project Start
2002-07-01
Project End
2007-06-30
Budget Start
2003-07-01
Budget End
2004-06-30
Support Year
2
Fiscal Year
2003
Total Cost
$352,440
Indirect Cost
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
020520466
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Srikrishna, Geetha; Nayak, Jonamani; Weigle, Bernd et al. (2010) Carboxylated N-glycans on RAGE promote S100A12 binding and signaling. J Cell Biochem 110:645-59
Srikrishna, Geetha; Freeze, Hudson H (2009) Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia 11:615-28
Sinha, Pratima; Okoro, Chinonyerem; Foell, Dirk et al. (2008) Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol 181:4666-75
Turovskaya, Olga; Foell, Dirk; Sinha, Pratima et al. (2008) RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis 29:2035-43
Leone, Marilisa; Freeze, Hudson H; Chan, Chui Sien et al. (2006) The Nuclear Overhauser Effect in the lead identification process. Curr Drug Discov Technol 3:91-100
Srikrishna, Geetha; Turovskaya, Olga; Shaikh, Raziya et al. (2005) Carboxylated glycans mediate colitis through activation of NF-kappa B. J Immunol 175:5412-22
Srikrishna, Geetha; Brive, Lena; Freeze, Hudson H (2005) Novel carboxylated N-glycans contain oligosaccharide-linked glutamic acid. Biochem Biophys Res Commun 332:1020-7